Cargando…
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
Methamphetamine (METH) abuse is a serious health and social problem worldwide. At present, however, there are no effective medications for the treatment of METH abuse. Of the intracellular METH target proteins, monoamine oxidase (MAO) is involved in the regulation of monoaminergic tone in the brain,...
Autores principales: | Kitanaka, Junichi, Kitanaka, Nobue, Takemura, Motohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155216/ https://www.ncbi.nlm.nih.gov/pubmed/21901055 |
Ejemplares similares
-
Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose
por: Kitanaka, Junichi, et al.
Publicado: (2016) -
Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice
por: Kitanaka, Nobue, et al.
Publicado: (2015) -
Memory Impairment and Reduced Exploratory Behavior in Mice after Administration of Systemic Morphine
por: Kitanaka, Junichi, et al.
Publicado: (2015) -
MAO-inhibitors in Parkinson's Disease
por: Riederer, Peter, et al.
Publicado: (2011) -
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
por: Teo, Kay Cheong, et al.
Publicado: (2013)